Cancer Guidance Program-Oncology Medication Coverage
Customize your policy alerts
Sign up for all MVP Health Care policy alerts
Know when MVP Health Care releases new policies or updates existing guidance.
Monitor payer policy activity
This policy defines clinical criteria used by the Optum Cancer Guidance Program to review prior authorization requests for oncology medications covered under MVP's medical benefit, including chemotherapy, immunotherapy, targeted therapies, oral oncolytics, hematology-supportive agents, and other listed oncology drug therapies.
No material clinical or coverage changes in this revision.
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.